133 tracked 13F filers disclose a position in CDXS as of the latest SEC 13F filings, a combined $103.3M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Aberdeen Group plc | $14.1M | 8.7M | ▲+9.0% Added · +714K sh | Q1 2026 | |
| 2 | BlackRock, Inc. | $11.5M | 7.0M | ▼−5.0% Reduced · −367K sh | Q1 2026 | |
| 3 | Opaleye Management Inc. | $11.1M | 6.8M | ▼−0.1% Reduced · −5K sh | Q1 2026 | |
| 4 | MILLENNIUM MANAGEMENT LLC | $6.5M | 4.0M | ▲+28% Added · +863K sh | Q1 2026 | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $6.0M | 3.7M | →First observed position No prior filed position | Q1 2026 | |
| 6 | Nantahala Capital Management, LLC | $8.2M | 3.6M | ▼−12% Reduced · −500K sh | Q2 2026 | |
| 7 | AMERIPRISE FINANCIAL INC | $5.5M | 3.4M | ▼−10% Reduced · −393K sh | Q1 2026 | |
| 8 | UBS Group AG | $3.6M | 2.2M | ▲+170% Added · +1.4M sh | Q1 2026 | |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $4.9M | 2.2M | ▲+15% Added · +277K sh | Q2 2026 | |
| 10 | STATE STREET CORP | $4.0M | 1.8M | ▲+5.4% Added · +90K sh | Q2 2026 | |
| 11 | JACOBS LEVY EQUITY MANAGEMENT, INC | $1.8M | 1.1M | ▼−4.2% Reduced · −47K sh | Q1 2026 | |
| 12 | D. E. Shaw & Co., Inc. | $1.6M | 980K | ▲+56% Added · +352K sh | Q1 2026 | |
| 13 | JANE STREET GROUP, LLC | $1.5M | 920K | ▲+207% Added · +620K sh | Q1 2026 | |
| 14 | VANGUARD PORTFOLIO MANAGEMENT LLC | $1.4M | 879K | →First observed position No prior filed position | Q1 2026 | |
| 15 | GOLDMAN SACHS GROUP INC | $1.3M | 825K | ▲+15% Added · +107K sh | Q1 2026 | |
| 16 | FRANKLIN TEMPLETON INC | $1.1M | 688K | ▼−7.1% Reduced · −52K sh | Q1 2026 | |
| 17 | NORTHERN TRUST CORP | $1.1M | 657K | ▲+1.8% Added · +12K sh | Q1 2026 | |
| 18 | AQR CAPITAL MANAGEMENT LLC | $992K | 609K | ▲+841% Added · +544K sh | Q1 2026 | |
| 19 | Man Group plc | $1.3M | 566K | ▲Added Added · +566K sh | Q2 2026 | |
| 20 | Post Resch Tallon Group Inc. | $1.3M | 563K | ▼−1.4% Reduced · −8K sh | Q2 2026 | |
| 21 | VANGUARD FIDUCIARY TRUST CO | $898K | 551K | →First observed position No prior filed position | Q1 2026 | |
| 22 | TUDOR INVESTMENT CORP ET AL | $877K | 538K | —Held | Q1 2026 | |
| 23 | PERKINS CAPITAL MANAGEMENT INC | $1.2M | 526K | ▼−0.3% Reduced · −1K sh | Q2 2026 | |
| 24 | MORGAN STANLEY | $771K | 473K | ▲+9.7% Added · +42K sh | Q1 2026 | |
| 25 | ALGERT GLOBAL LLC | $974K | 431K | ▲+118% Added · +233K sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 6 funds opened a new position in CDXS and 15 added to an existing one, while 19 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| NVIDIA CORPNVDA | 61 funds | $179.6B |
| MICROSOFT CORPMSFT | 60 funds | $122.7B |
| ELI LILLY & COLLY | 60 funds | $36.6B |
| APPLE INCAAPL | 59 funds | $139.0B |
| AMAZON.COM INCAMZN | 59 funds | $87.1B |
| ADVANCED MICRO DEVICESAMD | 59 funds | $16.5B |
| ALPHABET INC-CL CGOOG | 58 funds | $62.4B |
| MICRON TECHNOLOGY INCMU | 58 funds | $17.1B |
| WALMART INCWMT | 58 funds | $15.7B |
| BERKSHIRE HATHAWAY INC-CL BBRK/B | 58 funds | $15.5B |
| BROADCOM INCAVGO | 57 funds | $76.3B |
| META PLATFORMS INC-CLASS AMETA | 57 funds | $53.6B |
Ranked by how many of CDXS's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | De Vre Raymond | Director | Sell (S) | 3K | $6K |
| Feb 24, 2026 | Lutz Stefan | Chief Scientific Officer | Sell (S) | 6K | $7K |
| Feb 6, 2026 | MOORE ALISON | President and CEO, Director | Sell (S) | 4K | $5K |
| Feb 6, 2026 | Erbez Georgia | See Remarks | Sell (S) | 4K | $5K |
| Feb 6, 2026 | Lutz Stefan | Chief Scientific Officer | Sell (S) | 2K | $3K |
| Jan 7, 2026 | Lutz Stefan | CSO | Sell (S) | 5K | $8K |
| Dec 1, 2025 | Opaleye Management Inc. | 10% Owner | Sell (S) | 245K | $409K |
| Dec 1, 2025 | Opaleye Management Inc. | 10% Owner | Sell (S) | 9K | $14K |
| Nov 28, 2025 | Opaleye Management Inc. | 10% Owner | Sell (S) | 2K | $4K |
| Nov 28, 2025 | Opaleye Management Inc. | 10% Owner | Sell (S) | 105K | $184K |
| Nov 26, 2025 | Opaleye Management Inc. | 10% Owner | Sell (S) | 5K | $9K |
| Nov 26, 2025 | Opaleye Management Inc. | 10% Owner | Sell (S) | 148K | $258K |
Connected entities for CDXS
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/CDXS/capital-change-brief"
Use Arkolith's capital_change_brief for CDXS. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CDXS. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.